Fortress Biotech Inc. | Mutual Funds
Mutual Funds that own Fortress Biotech Inc.
iShares Russell 2000 ETF
677,807
1.25%
-363
0%
09/06/2018
Vanguard Total Stock Market Index Fund
644,427
1.19%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
371,941
0.68%
0
0%
07/31/2018
iShares Russell 2000 Growth ETF
366,535
0.67%
0
0.01%
09/06/2018
Engex Fund
264,800
0.49%
0
6.75%
12/31/2017
Fidelity Spartan Extended Market Index Fund
160,408
0.3%
0
0%
07/31/2018
iShares Micro Cap ETF
91,720
0.17%
0
0.02%
09/06/2018
70,802
0.13%
10,461
0.01%
07/31/2018
CREF Stock Account
69,482
0.13%
0
0%
03/31/2018
Fidelity Spartan Small Cap Index Fund
66,666
0.12%
4,243
0%
04/30/2018
| Address |
2 Gansevoort Street
New York New York 10014
United States
|
|
Employees
|
- |
| Website |
http://www.fortressbiotech.com |
| Updated |
07/08/2019 |
| Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation, an independent brokerage company. |
